SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-001401
Filing Date
2022-03-03
Accepted
2022-03-03 08:35:26
Documents
46
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cns_i10k-123121.htm   iXBRL 10-K 775367
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cns_ex2301.htm EX-23.1 2817
3 CERTIFICATION cns_ex3101.htm EX-31.1 10002
4 CERTIFICATION cns_ex3102.htm EX-31.2 9802
5 CERTIFICATION cns_ex3201.htm EX-32.1 3625
6 CERTIFICATION cns_ex3202.htm EX-32.2 3381
  Complete submission text file 0001683168-22-001401.txt   3264657

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cnsp-20211231.xsd EX-101.SCH 23369
8 XBRL CALCULATION FILE cnsp-20211231_cal.xml EX-101.CAL 28454
9 XBRL DEFINITION FILE cnsp-20211231_def.xml EX-101.DEF 101311
10 XBRL LABEL FILE cnsp-20211231_lab.xml EX-101.LAB 235964
11 XBRL PRESENTATION FILE cnsp-20211231_pre.xml EX-101.PRE 181418
40 EXTRACTED XBRL INSTANCE DOCUMENT cns_i10k-123121_htm.xml XML 322753
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 22706826
SIC: 2834 Pharmaceutical Preparations